Literature DB >> 33483614

Implication of PIGA genotype on erythrocytes phenotype in Paroxysmal Nocturnal Hemoglobinuria.

Carmelo Gurnari1,2, Simona Pagliuca1,3, Bhumika J Patel1,4, Hassan Awada1, Sunisa Kongkiatkamon1, Laila Terkawi1, Misam Zawit1, Seth Corey1, Alan E Lichtin1, Hetty E Carraway1, Adam Wahida5, Valeria Visconte1, Jaroslaw P Maciejewski6.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2021        PMID： 33483614      PMCID： PMC8299540          DOI： 10.1038/s41375-020-01113-0

Source DB:  PubMed          Journal:  Leukemia        ISSN： 0887-6924            Impact factor:   12.883


× No keyword cloud information.
  15 in total

1.  Genetic and environmental effects in paroxysmal nocturnal hemoglobinuria: this little PIG-A goes "Why? Why? Why?".

Authors:  N S Young; J P Maciejewski
Journal:  J Clin Invest       Date:  2000-09       Impact factor: 14.808

Review 2.  Diagnosis and management of paroxysmal nocturnal hemoglobinuria.

Authors:  Charles Parker; Mitsuhiro Omine; Stephen Richards; Jun-Ichi Nishimura; Monica Bessler; Russell Ware; Peter Hillmen; Lucio Luzzatto; Neal Young; Taroh Kinoshita; Wendell Rosse; Gerard Socié
Journal:  Blood       Date:  2005-07-28       Impact factor: 22.113

3.  Molecular basis of the heterogeneity of expression of glycosyl phosphatidylinositol anchored proteins in paroxysmal nocturnal hemoglobinuria.

Authors:  M Endo; R E Ware; T M Vreeke; S P Singh; T A Howard; A Tomita; M H Holguin; C J Parker
Journal:  Blood       Date:  1996-03-15       Impact factor: 22.113

4.  High-Sensitivity Detection of PNH Red Blood Cells, Red Cell Precursors, and White Blood Cells.

Authors:  D Robert Sutherland; Andrea Illingworth; Michael Keeney; Stephen J Richards
Journal:  Curr Protoc Cytom       Date:  2015-04-01

5.  Complement and inflammasome overactivation mediates paroxysmal nocturnal hemoglobinuria with autoinflammation.

Authors:  Britta Höchsmann; Yoshiko Murakami; Makiko Osato; Alexej Knaus; Michi Kawamoto; Norimitsu Inoue; Tetsuya Hirata; Shogo Murata; Markus Anliker; Thomas Eggermann; Marten Jäger; Ricarda Floettmann; Alexander Höllein; Sho Murase; Yasutaka Ueda; Jun-Ichi Nishimura; Yuzuru Kanakura; Nobuo Kohara; Hubert Schrezenmeier; Peter M Krawitz; Taroh Kinoshita
Journal:  J Clin Invest       Date:  2019-12-02       Impact factor: 14.808

6.  Practical guidelines for the high-sensitivity detection and monitoring of paroxysmal nocturnal hemoglobinuria clones by flow cytometry.

Authors:  D Robert Sutherland; Michael Keeney; Andrea Illingworth
Journal:  Cytometry B Clin Cytom       Date:  2012-04-25       Impact factor: 3.058

7.  Paroxysmal nocturnal hemoglobinuria: natural history of disease subcategories.

Authors:  Régis Peffault de Latour; Jean Yves Mary; Célia Salanoubat; Louis Terriou; Gabriel Etienne; Mohamad Mohty; Sophie Roth; Sophie de Guibert; Sebastien Maury; Jean Yves Cahn; Gerard Socié
Journal:  Blood       Date:  2008-06-05       Impact factor: 22.113

8.  Deficiency of the GPI anchor caused by a somatic mutation of the PIG-A gene in paroxysmal nocturnal hemoglobinuria.

Authors:  J Takeda; T Miyata; K Kawagoe; Y Iida; Y Endo; T Fujita; M Takahashi; T Kitani; T Kinoshita
Journal:  Cell       Date:  1993-05-21       Impact factor: 41.582

9.  Clonal PIGA mosaicism and dynamics in paroxysmal nocturnal hemoglobinuria.

Authors:  Michael J Clemente; Bartlomiej Przychodzen; Cassandra M Hirsch; Yasunobu Nagata; Taha Bat; Marcin W Wlodarski; Tomas Radivoyevitch; Hideki Makishima; Jaroslaw P Maciejewski
Journal:  Leukemia       Date:  2018-04-25       Impact factor: 11.528

10.  Deficient biosynthesis of N-acetylglucosaminyl-phosphatidylinositol, the first intermediate of glycosyl phosphatidylinositol anchor biosynthesis, in cell lines established from patients with paroxysmal nocturnal hemoglobinuria.

Authors:  M Takahashi; J Takeda; S Hirose; R Hyman; N Inoue; T Miyata; E Ueda; T Kitani; M E Medof; T Kinoshita
Journal:  J Exp Med       Date:  1993-02-01       Impact factor: 14.307
View more
  4 in total

Review 1.  When does a PNH clone have clinical significance?

Authors:  Daria V Babushok
Journal:  Hematology Am Soc Hematol Educ Program       Date:  2021-12-10

Review 2.  Current Opinions on the Clinical Utility of Ravulizumab for the Treatment of Paroxysmal Nocturnal Hemoglobinuria.

Authors:  Carmelo Gurnari; Ishani Nautiyal; Simona Pagliuca
Journal:  Ther Clin Risk Manag       Date:  2021-12-14       Impact factor: 2.423

3.  Is nature truly healing itself? Spontaneous remissions in Paroxysmal Nocturnal Hemoglobinuria.

Authors:  Carmelo Gurnari; Simona Pagliuca; Tariq Kewan; Waled Bahaj; Minako Mori; Bhumika J Patel; Valeria Visconte; Jaroslaw P Maciejewski
Journal:  Blood Cancer J       Date:  2021-11-27       Impact factor: 11.037

Review 4.  Managing Fatigue in Patients with Paroxysmal Nocturnal Hemoglobinuria: A Patient-Focused Perspective.

Authors:  Bruno Fattizzo; Francesca Cavallaro; Esther Natalie Oliva; Wilma Barcellini
Journal:  J Blood Med       Date:  2022-06-17
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.